Immunotherapy in Esophagogastric Cancer

Abstract: The uses of immune checkpoint inhibitors have now been advanced to include the first-line treatment of esophagogastric cancers. Initially approved for the treatment of chemotherapy-refractory […]

Optimal Duration of Adjuvant Therapy for Stage III Colon Cancer

Abstract: Colon cancer remains a major cause of mortality worldwide. Following adequate surgical resection of lymph node–positive colon cancer, the standard of care since 2004 […]

Adjuvant Therapy in High-Risk Prostate Cancer

Abstract: Although the prognosis in patients with localized prostate cancer is positive overall, high-risk localized disease is responsible for significant cancer-related morbidity and mortality following […]

Does Adjuvant Therapy for High-Risk Melanoma With Either Immunotherapy or Targeted Therapy Affect Therapeutic Choices at Relapse?

H&O What are the main treatments used for adjuvant therapy in melanoma? MP The drugs that have received approval from the US Food and Drug […]

What Is the Optimal Duration of Adjuvant Therapy in Colon Cancer?

H&O Which patients with colon cancer require adjuvant therapy? AS Patients who are considered to be at high risk for recurrence require adjuvant therapy. This […]